Skip to main content
Home ViewHub

Main Menu

  • About
  • Vaccine Data Explorer
    • COVID Vaccines
    • Haemophilus Influenzae Type B Vaccine
    • Human Papillomavirus Vaccine
    • Inactivated Polio Vaccine
    • Measles-Rubella Vaccine
    • Measles-containing-vaccine second-dose
    • Pneumococcal Conjugate Vaccine
    • Rotavirus Vaccine
    • Typhoid Conjugate Vaccine
  • Resources
  • Country Pages
  • Topic Pages
COVID Vaccines (COVID) Haemophilus Influenzae Type B Vaccine (Hib) Human Papillomavirus Vaccine (HPV) Inactivated Polio Vaccine (IPV) Measles-containing-vaccine second-dose (MCV2) Measles-Rubella Vaccine (MR) Pneumococcal Conjugate Vaccine (PCV) Rotavirus Vaccine (Rota) Typhoid Conjugate Vaccine (Typhoid)
Introduction & Use Access & Coverage Data Download Disease Burden Impact Studies Product Characteristics Resources
Explore other pages for this Antigen
  • January 2023 VIEW-hub Report on Global Vaccine Introduction and Implementation
    Feb 22, 2023
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • PCV Product Serotypes
    Feb 11, 2023
    Results & Summaries

    This table shows the serotypes covered by the current pneumococcal conjugate vaccine products and the three additional products that are in the development pipeline. 

  • October 2022 VIEW-hub Report on Global Vaccine Introduction and Implementation
    Nov 1, 2022
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • July 2022 VIEW-hub Report in Global Vaccine Introduction and Implementation
    Aug 2, 2022
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • March 2022 VIEW-hub Report in Global Vaccine Introduction and Implementation
    Apr 18, 2022
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • September 2021 VIEW-hub Report in Global Vaccine Introduction and Implementation
    Oct 29, 2021
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • June 2021: VIEW-hub Report
    Aug 2, 2021
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • March 2021 VIEW-hub Report on Global Vaccine Introduction and Implementation
    May 7, 2021
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • December 2020 VIEW-hub Report: Global Vaccine Introduction and Implementation
    Feb 8, 2021
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the 73 Gavi countries

  • June 2020 VIEW-hub Report: Global Vaccine Introduction and Implementation
    Aug 10, 2020
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of June 2020.

Pagination

  • 1
  • 2
  • Next
  • Last

Explore more data and content

Introduction & Use
Access & Coverage
Data Download
Disease Burden
Impact Studies
Product Characteristics

ViewHub Logo

A project of:

Citation

International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub. www.view-hub.org. Accessed: .

Contact

Contact Us

If you have any questions or comments, or would like to notify us of any technical issues you are experiencing with VIEW-hub, please get in touch. We welcome and appreciate your valuable feedback.

Built by Graphicacy